Reported 1 day ago
CVS exceeded earnings expectations for the fourth quarter and full year 2024, with full-year revenue at $372.8 billion and stock rising 15%. Despite challenges in its healthcare benefits segment and a drop in overall profits to $8.5 billion, the company's pharmacy and consumer wellness sectors showed growth. CVS provided adjusted earnings per share guidance for 2025 but did not disclose revenue forecasts.
Source: YAHOO